An Open-Label Pharmacokinetic Drug Interaction Study of Folic Acid and 250 Mcg NGM/35 Mcg EE (ORTHO-CYCLEN) in Healthy Women
Phase of Trial: Phase I
Latest Information Update: 28 Apr 2010
At a glance
- Drugs Ethinylestradiol/norgestimate; Folic acid
- Indications Congenital abnormalities; Pregnancy
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 31 Aug 2018 Biomarkers information updated
- 28 Apr 2010 Actual patient number (47) added as reported by ClinicalTrials.gov.
- 29 Jul 2008 New trial record.